DWM
ISEE

Doyle Wealth Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Doyle Wealth Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-50
Closed – – 806
2018
Q4 		$0 Buy
+50
New +$97 ﹤0.01% 868

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Doyle Wealth Management's ISEE Position: Q1 2019 in Review

Doyle Wealth Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2019, closing a stake of 50 shares.

Doyle Wealth Management first reported a position in ISEE in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 58 funds tracked by Wall St. Rank hold ISEE as of Q1 2019.

  • Doyle Wealth Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Doyle Wealth Management sold 50 IVERIC bio, Inc. Common Stock shares in Q1 2019.
  • Doyle Wealth Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Doyle Wealth Management's IVERIC bio, Inc. Common Stock position peaked at $0 in Q4 2018.
  • 58 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2019.

Based on Doyle Wealth Management's 13F filing for Q1 2019, filed 13 May 2019.